Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

6,778 total articles

Century Therapeutics Selected for Oral Presentation of CNTY‑813 Preclinical Data at the American Diabetes Association 86th Scientific Sessions

Century Therapeutics Selected for Oral Presentation of CNTY‑813 Preclinical Data at the American Diabetes Association 86th Scientific Sessions

Century Therapeutics announced an oral presentation of their CNTY-813 iPSC-derived islet cell replacement therapy at the American Diabetes Association's 86th Scientific Sessions. The company highlights progress in developing a scalable, off-the-shelf cell therapy platform engineered to reduce reliance on immunosuppressive drugs for type 1 diabetes …

Jakks Pacific Reports First Quarter 2026 Financial Results

Jakks Pacific Reports First Quarter 2026 Financial Results

JAKKS Pacific reported a 6% decline in net sales to $106.7 million in Q1 2026 compared to the previous year, with a 7% drop in Toys/Consumer Products sales offset partially by a 13% increase in Costumes sales. The company experienced a wider operating loss of $5.6 million and a net loss attributable to common stockholders of $4.3 million, worse tha…

Akebia Therapeutics to Report First Quarter 2026  Financial Results and Discuss Recent Business Highlights

Akebia Therapeutics to Report First Quarter 2026 Financial Results and Discuss Recent Business Highlights

Akebia Therapeutics plans to release its first quarter 2026 financial results on May 7, 2026, prior to market open. The company will hold a conference call at 8:00 a.m. EDT the same day to discuss financials and recent business highlights. Akebia is a biopharmaceutical firm focused on kidney disease treatments, headquartered in Cambridge, Massachus…

Sinclair Declares $0.25 per Share Quarterly Cash Dividend

Sinclair Declares $0.25 per Share Quarterly Cash Dividend

Sinclair, Inc., a diversified media company listed on Nasdaq under ticker SBGI, declared a quarterly cash dividend of $0.25 per share on its Class A and Class B common stock. The dividend will be paid on June 9, 2026, to shareholders of record as of May 26, 2026. Sinclair owns and operates a vast network of television stations, digital media proper…

Magnite to Participate in Upcoming Financial Conferences

Magnite to Participate in Upcoming Financial Conferences

Magnite, the largest independent sell-side advertising company, announced its executive team's participation in several upcoming financial conferences including Needham, B. Riley, and Evercore, featuring multiple fireside chats and investor meetings. The company provides technology enabling publishers to monetize content across various formats such…

iRhythm Holdings Announces First Quarter 2026 Financial Results

iRhythm Holdings Announces First Quarter 2026 Financial Results

iRhythm Holdings announced its financial results for Q1 2026, posting a 25.7% increase in revenue to $199.4 million and a significant improvement in net loss, down to $13.9 million from $30.7 million a year earlier. The company achieved gross margin expansion and improved adjusted EBITDA margin, driven by strong demand for its cardiac monitoring pr…

Adeia Receives Credit Rating Upgrade from S&P Global Ratings

Adeia Receives Credit Rating Upgrade from S&P Global Ratings

Adeia Inc., a technology company focused on semiconductor and media innovation, announced that S&P Global Ratings upgraded its issuer credit rating from 'BB-' to 'BB' with a stable outlook. This reflects Adeia's strong execution on strategic priorities including financial strengthening, consistent cash flow generation, and disciplined balance sheet…

Trevi Therapeutics Announces Oral Presentation and Multiple Posters Accepted at the American Thoracic Society (ATS) 2026 International Conference

Trevi Therapeutics Announces Oral Presentation and Multiple Posters Accepted at the American Thoracic Society (ATS) 2026 International Conference

Trevi Therapeutics announced acceptance of an oral presentation and multiple poster presentations at the 2026 American Thoracic Society International Conference, highlighting data from their Phase 2b CORAL trial and Phase 2a RIVER trial evaluating nalbuphine ER for chronic cough in IPF and refractory chronic cough patients. The data include primary…

Root, Inc. to Participate in Upcoming Investor Conferences

Root, Inc. to Participate in Upcoming Investor Conferences

Root, Inc., a technology-driven car insurance company, announced it will participate in the Wells Fargo Financial Services Investor Conference and the Morgan Stanley US Financials Conference. Root's CEO and CFO will engage in one-on-one and group meetings with institutional investors but will not hold public presentations. Investor materials are av…

SPS Commerce Reports First Quarter 2026 Financial Results

SPS Commerce Reports First Quarter 2026 Financial Results

SPS Commerce, Inc. announced its Q1 2026 financial results showing 6% revenue growth year-over-year to $192.1 million and 7% increase in adjusted EBITDA to $57.9 million. The company launched MAX, an AI-driven offering embedded in supply chain workflows designed to enhance customer trading relationships. EPS on a non-GAAP basis rose to $1.10 from $…

Jefferson Capital to Announce First Quarter 2026 Results

Jefferson Capital to Announce First Quarter 2026 Results

Jefferson Capital, Inc., a leading purchaser and manager of charged-off consumer accounts, will announce its first quarter 2026 financial results after market close on May 14, followed by a webcast to discuss the results. The company operates across the US, Canada, UK, and Latin America, servicing secured and unsecured assets for major creditors an…

DMC Global Reports First Quarter Financial Results

DMC Global Reports First Quarter Financial Results

DMC Global Inc. reported Q1 2026 financial results reflecting a 15% year-over-year sales decline to $135.6 million and adjusted EBITDA of $3.9 million, down from $14.4 million a year ago, impacted by geopolitical tensions in the Middle East, higher raw material prices, and softer demand in key markets. All business segments—Arcadia Products, DynaEn…

RadNet and Trinity Health’s Saint Alphonsus Health System Launch a Multi-Site Joint Venture in Boise, Idaho, to Include a Broad Technology Deployment of DeepHealth Solutions

RadNet and Trinity Health’s Saint Alphonsus Health System Launch a Multi-Site Joint Venture in Boise, Idaho, to Include a Broad Technology Deployment of DeepHealth Solutions

RadNet, Inc. announced a strategic joint venture with Saint Alphonsus Health System in Boise, Idaho, through a majority stake in Intermountain Medical Imaging. The partnership integrates RadNet's outpatient diagnostic imaging expertise and DeepHealth AI technology solutions with Saint Alphonsus's regional healthcare network to improve clinical and …

Cocrystal Pharma Presentation at ICAR 2026 Highlights Mechanism of Action and Clinical Advancement of CDI-988 for the Prevention and Treatment of Norovirus Infection

Cocrystal Pharma Presentation at ICAR 2026 Highlights Mechanism of Action and Clinical Advancement of CDI-988 for the Prevention and Treatment of Norovirus Infection

Cocrystal Pharma presented promising progress on CDI-988, an oral direct-acting antiviral targeting norovirus, at ICAR 2026. The Phase 1b human challenge study is fully enrolled in its initial cohort, aiming to establish proof-of-concept for prevention and treatment. CDI-988 targets a conserved protease region across all norovirus strains and coron…

Strata Acquires Ohio Valley Perfusion Associates

Strata Acquires Ohio Valley Perfusion Associates

Strata Critical Medical, Inc. completed the acquisition of Ohio Valley Perfusion Associates, a regional provider of perfusion services in Ohio and Pennsylvania. The acquisition strengthens Strata's clinical platform in these regions, enabling expansion of services like ECMO support and organ recovery. The purchase aligns with Strata's M&A strategy,…

LPL Financial Announces First Quarter 2026 Results

LPL Financial Announces First Quarter 2026 Results

LPL Financial Holdings Inc. announced solid financial results for Q1 2026, highlighting a 19% increase in net income to $356 million and a 9% rise in adjusted EPS to $5.60. The company achieved a 30% year-over-year increase in total client assets to $2.3 trillion, with advisory assets growing 42% to $1.4 trillion. Strategic initiatives including pi…